NCT04951869View on ClinicalTrials.gov

: Protescal: Prevention of Hypertrophic Scar and Keloid Formation Post Caesarean Section

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

April 26, 2017

Primary Completion Date

October 31, 2017

Study Completion Date

November 16, 2017

Conditions
Caesarean WoundHypertrophic Surgical ScarKeloid Scar Following Surgery
Interventions
DRUG

Protescal gel

Protescal gel (0.5 mL) was again applied over the subcutaneous tissue prior to skin closure in Protescal group

Trial Locations (1)

56000

Universiti Kebangsaan Malaysia Medical Centre, Cheras

All Listed Sponsors
lead

Universiti Kebangsaan Malaysia Medical Centre

OTHER

NCT04951869 - : Protescal: Prevention of Hypertrophic Scar and Keloid Formation Post Caesarean Section | Biotech Hunter | Biotech Hunter